Secured Dismissal for Pharmaceutical Client in High Court Case
Secured dismissal of a case before the High Court in which the claimant alleged that it had reached a legally binding agreement with our client, a Mumbai-headquartered pharmaceutical company, for the supply of drug for the Canadian market.
$200 Million Arbitration Proceedings for Breach of Contract
Acted for an African natural resources company in $200 million LCIA arbitration proceedings concerning a breach of contract.
Acted for Client in Connection with Preference, Undervalue Transaction Claims
Acted for a U.K. company in connection with preference and undervalue transaction claims threatened against it by an administrator.
Advised Leading International Business in Issues Related to a U.K. Social Media Campaign
Advised a leading international business concerning issues arising out of its proposed U.K. social media campaign.
Advised on Division of Multinational Business Including Parallel Proceedings in the U.K. and U.S.
Advised on a high-value dispute concerning the division of a multinational business (with parallel proceedings in the High Court in London and across the U.S.).
Advised Overseas Pharma Company in Defense of High Court Proceedings
Advised a leading overseas pharma company in its defense of significant High Court proceedings.
Advised Pharma Companies on U.K.’s Pharmaceutical Price Regulation Schemes
Advised several pharmaceutical companies about matters concerning the U.K.’s Pharmaceutical Price Regulation Schemes.
Advised U.K. Pharma Company in Defamatory Reporting Case
Advised a U.K. pharmaceutical company concerning defamatory reporting in the media about one of its key products.
Defense in $100 Million Proceedings in English Commercial Court
Acted for a defendant in $100 million proceedings in the English Commercial Court.
Shareholders Dispute for Ultra High-Net-Worth Individual
Advised an ultra high-net-worth individual in a significant multi-jurisdictional shareholders dispute.